Blocking HSP90 Addiction Inhibits Tumor Cell Proliferation, Metastasis Development, and Synergistically Acts with Zoledronic Acid to Delay Osteosarcoma Progression

Ory, B., Baud'huin, M.E., Verrecchia, F. et al. (7 more authors) (2016) Blocking HSP90 Addiction Inhibits Tumor Cell Proliferation, Metastasis Development, and Synergistically Acts with Zoledronic Acid to Delay Osteosarcoma Progression. Clinical Cancer Research, 22 (10). pp. 2520-2533. ISSN 1078-0432

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2015 American Association for Cancer Research.
Dates:
  • Published (online): 28 December 2015
  • Accepted: 4 December 2015
  • Published: May 2016
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Medicine (Sheffield) > Division of Genomic Medicine (Sheffield) > Department of Oncology (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 28 Apr 2016 11:59
Last Modified: 23 Jun 2017 16:02
Published Version: http://dx.doi.org/10.1158/1078-0432.CCR-15-1925
Status: Published
Publisher: American Association for Cancer Research
Refereed: Yes
Identification Number: https://doi.org/10.1158/1078-0432.CCR-15-1925
Related URLs:

Download not available

A full text copy of this item is not currently available from White Rose Research Online

Share / Export

Statistics